openPR Logo
Press release

Celiac Disease: ORGENTEC Diagnostika Launches New Blood Tests

07-13-2010 11:28 AM CET | Health & Medicine

Press release from: ORGENTEC Diagnostika

Mainz, 09. July 2010 – ORGENTEC Diagnostika (orgentec.com), developer of blood test systems, has launched three new diagnostic tests for diagnosing celiac disease. This new test line completes ORGENTEC’s product portfolio for accurate diagnosis of gastrointestinal disorders.

Celiac disease is an (auto)immunologically mediated intestinal intolerance to proteins (gluten) from wheat and other cereals in genetically predisposed children and adults. Despite initial estimates, celiac disease is more common than previously assumed. Besides classical celiac disease with fully expressed symptoms such as abdominal pain, vomiting, diarrhoea, weight lost and failure to thrive, especially in adults, the disease can occur with atypical milder symptoms and in latent forms.

Serological diagnosis of celiac disease is based on determination of autoantibodies against tissue transglutaminase (anti-tTG antibodies, anti-tTG) and antibodies directed against native gliadin (anti-gliadin antibodies, AGA), a component of gluten. Whereas serum autoantibodies to tissue transglutaminase are highly specific markers for celiac disease, antibodies to gliadin have lost in importance for diagnosis. But they are still used for monitoring of adherence to the gluten-free diet which is until now the only cure for the disease.

Native gliadin is a mixture of several proteins with varying immunogenic potential. Recently, several gliadin epitopes have been identified that are capable of inducing a strong immune response. These epitopes are generated via deamidation of gliadin by the enzyme tissue transglutaminase (tTG). The use of these deamidated gliadin proteins, DGP, in the ORGENTEC Anti-DGP assays has significantly improved the usefulness of gliadin antibodies for diagnosis of celiac disease.

Celiac disease is prevalent in up to 1% in Europe and in populations of European ancestry. Even though the rate of diagnosis has increased in recent years, the majority of affected individuals are still undiagnosed. Diagnosing celiac disease is important, because a gluten-free diet typically resolves symptoms and can prevent subsequent long-term damages. Because celiac disease is spread worldwide and has also been found in regions where it was considered extremely rare, greater levels of awareness and attention on gluten intolerance are needed in both the Old and the New World.

About ORGENTEC Diagnostika:
ORGENTEC Diagnostika develops, manufactures and markets reagents and test kits for autoimmune disease detection. Products are for the determination of various antibodies in patient serum: ELISA test systems, blot tests, immunofluorescence tests and reagents, random access analyzer Alegria® for autoimmune diagnostics, rapid test rheumachec® for diagnosing rheumatoid arthritis. www.orgentec.com

ORGENTEC Diagnostika GmbH
Public Relations
Tobias Stolzenberg
Dr. Friederike Hammar
Carl-Zeiss-Strasse 49
55129 Mainz, Germany
Tel. +49 6131 9258-677, -674
Fax +49 6131 9258-58
pr@orgentec.com
www.orgentec.com
www.autoimmunityblog.wordpress.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Celiac Disease: ORGENTEC Diagnostika Launches New Blood Tests here

News-ID: 138142 • Views: 1353

More Releases from ORGENTEC Diagnostika

Fully Automated Chlamydia Diagnostics from ORGENTEC
Mainz, June 19, 2012 – ORGENTEC Diagnostika (www.orgentec.com) has introduced six new tests for the diagnosis of infectious diseases. The new ELISA tests detect antibodies against Chlamydia trachomatis and Chlamydia pneumoniae. In addition, these test systems make it possible to differentiate between acute, latent, and chronic infection with these widespread bacterial pathogens. The new tests for the serological diagnosis of Chlamydia were developed specifically for Alegria®, ORGENTEC Diagnostika’s random access analyser.
Online Immunofluorescence Guide for Diagnosis of Autoimmune Diseases
Mainz, May 09 2012 – From now on the Immunofluorescence Guide for the Modern Autoimmunity Laboratory is available as a free ebook. The online reference work with numerous pictures of immunofluorescence patterns is accessible from the ORGENTEC Diagnostika website (www.orgentec.com) and from the website of the GRÜNE CLUB AUTOIMMUN (www.der-gruene-club.at). The online guide is public domain without login or registration. Whether it is the immunofluorescence pattern of antinuclear antibodies (ANA) on
Autoantibody Diagnostics in Autoimmune Liver Diseases
ORGENTEC Diagnostika (www.orgentec.com) has developed four new laboratory tests for the diagnosis of autoimmune liver diseases. These tests are now on the market. They are based on ELISA technology and were specifically developed for fully automated analysis with Alegria®. The new tests systems, called Anti-Sp100, Anti-gp210, Anti-LKM-1, and Anti-SLA, reliably detect specific autoantibodies that are characteristic of various autoimmune liver diseases. The tests thus also allow for reliable differentiation between these
A New Healthcare App: ORGENTEC Autoimmunity Guide
The ORGENTEC Autoimmunity Guide is now available for download from the Apple iTunes App Store and the Android Market. This app from Mainz-based ORGENTEC Diagnostika GmbH (www.orgentec.com) makes it possible to call up information about autoimmune diseases easily and comfortably from a smartphone or tablet – precisely, compactly, and without extensive searching. The ORGENTEC app offers comprehensive information about the diagnosis and monitoring of autoimmune diseases by means of antibody detection.

All 5 Releases


More Releases for Mainz

Solar Photovoltaic in Germany Market Insights to 2030 by Top Players UniCredit B …
Solar Photovoltaic (PV) in Germany, Market Outlook to 2030, Update 2017-Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles Summary "Solar Photovoltaic (PV) in Germany, Market Outlook to 2030, Update 2017-Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles", is the latest report from Publisher, the industry analysis specialists that offer comprehensive information and understanding of the Solar Photovoltaic (PV) market in Germany. Get Sample
TRON receives three-year research grant from the Falconwood Foundation to develo …
Mainz, February 14, 2018 - TRON (Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz, Germany), an internationally recognized leader in tumor immunology and cancer therapy research, has announced a three-year grant from the Falconwood Foundation, New York, USA, totalling 3 Million Euros. The grant supports the launch of a new research project to identify biomarkers specific for neuroendocrine tumors (NETs) that are crucial for the
Prof. Dr. Cornelis Melief Receives Honorary Doctorate from Johannes Gutenberg Un …
- Ceremony Conventio Medicinae held at University Medical Center Leiden, The Netherlands, October 26, 2017 – ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company, today announced that its Chief Scientific Officer, Prof. Cornelis Melief, has received an honorary doctorate from the University Medical Center of Johannes Gutenberg University Mainz, Germany. The honorary doctorate was awarded during a festive ceremony in Mainz on October 25, 2017. Prof. Melief was recognized for his lifetime achievements
Research project by iba AG and the Johannes Gutenberg University in Mainz
Flat products in metal processing industry are produced in several steps. The individual process steps are usually not interconnected directly, but are separated by transportation routes and interim storage facilities. When the coils are supplied to the next process step, they might be mixed up. For identifying the coils, iba AG has developed in cooperation with the Johannes Gutenberg University in Mainz mathematical algorithms and processes that are based on
Coface Arena: Back Straight Becomes ORGENTEC Stands
The Mainz-based company ORGENTEC Diagnostika has extended its involvement with 1. FSV Mainz 05 and will continue to sponsor stands at the new Coface Arena in Mainz. As they did in the Bruchweg Stadium, the globally active company, which specializes in laboratory tests, will keep the naming rights for the back straight in the new stadium built for FSV Mainz 05 for three years. In addition, ORGENTEC Diagnostika will have a
iVISION Scanware: Automated Evaluation of Immunoblots
Mainz, 06/12/2010 – With the introduction of iVISION Scanware, ORGENTEC Diagnostika has made it possible to automate the evaluation of immunoblots. The software allows these effective and robust test systems to be objectively assessed and the laboratory test results efficiently stored and archived. By graphically representing test results, the software very effectively aids physicians and laboratory personnel in interpreting results and makes it possible to obtain a diagnosis within a few